Find Faculty

Satish Vishram Rojekar, PhDSatish Rojekar (Preferred Name)

img_Satish Vishram Rojekar
ASSISTANT PROFESSOR | Pharmacological Sciences
646-256-9065
email
Research Topics
Adipose, Aging, Alzheimer's Disease, Antibody Development, Antivirals, Biomechanics/Bioengineering, Biomedical Sciences, Biophysics, Blood-Brain Barrier, Cellular Immunity, Dermatology, Drug Design and Discovery, Drug Resistance, Endocrinology, Gene Therapy, HIV/AIDS, Immunology, Infectious Disease, Intracellular Transport, Mass Spectrometry, Nanotechnology, Obesity, Osteoporosis, Oxidative Stress, Personalized Medicine, Pharmacology, Positron Emission Tomography, Technology & Innovation, Translational Research, Vaccine Development, Viruses and Virology
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT), Immunology [IMM], Microbiology [MIC], Neuroscience [NEU]
New topic
Dr. Satish Rojekar is an Assistant Professor at the Icahn School of Medicine at Mount Sinai and Director of the Drug Development and Nanomedicine Core at the Institute for Translational Medicine and Pharmacology. He develops drug delivery technologies that make treatments for chronic diseases work better, safer and more easily for patients. His lab develops monoclonal antibody formulations, including lyophilized products, for obesity, osteoporosis and Alzheimer's disease, with the goal of reaching IND-enabling studies. He also works on lipid nanoparticles for gene delivery and on microneedle drug delivery. His doctoral research developed nanostructured lipid carriers that deliver HIV drugs to viral reservoirs. Dr. Rojekar leads CMC and preclinical development for small and large molecules. He holds multiple patents, serves as a journal editor, and is a member of AAPS, CRS, the Endocrine Society, ASBMR and the British Society for Nanomedicine. He welcomes industry collaborations.

B. Pharm, Government College of Pharmacy

M.Pharm, Institute of Chemical Technology

Newton-Bhabha Fellow, Queens University

PhD, Institute of Chemical Technology

Professional Certification GLP, Biopharma Institute

Scientific Leadership Development Program, Icahn School of Medicine at Mount Sinai

Postdoctoral Fellow, Icahn School of Medicine at Mount Sinai

Professional Certification GCP (ICH Focus), CITI Good Clinical Practice

2026

Eugenia Rosemberg Travel Award

Endocrine Society, USA

2026

Young Investigator Award

American Society for Bone and Mineral Research (ASBMR)

2026

Academic Editor

Nature Scientific Reports

2026

Associate Editor

3 Biotech (Springer Nature)

2024

4th Annual XSeed Award (2024): Finalist

Deerfield Management and the NYC Economic Development Corporation, NYC, USA

2024

Academic Editor

Scientifica, Pharmaceutics (Wiley)

2024

Associate Editor

Frontiers in Cellular and Infection Microbiology

2024

Nominated full-time member

Sigma Xi, Scientific Research Honor Society, USA

2023

Academic Editor

PLOS One

2019

Newton-Bhabha Fellow

Queens University, Belfast, UK

65
Publications

Selected Publications

Corrigendum to “From discovery to therapeutic development of monoclonal antibodies” [J. Control. Release., Volume 396, 10 August 2026, Article 115034]. Satish Rojekar, Amol D. Gholap, Anusha R. Pallapati, Rauf Latif, Pavimol Angsantikul, Nagavendra Kommineni, Farhath Sultana, Anne Macdonald, Darya Vasilyeva, Steven Sims, Surabhi Parte, Clement Haeck, Rukmani Pandey, Judit Gimenez-Roig, Anisa Gumerova, Uliana Cheliadinova, Georgii Pevnev, Guzel Burganova, Zehra Tumoglu, Maryam Mansoori, Wei Yi, Orly Barak, Susan Hutchison, Francisco Fueyo González, Ki A. Goosens, Weibin Zhou, Vitaly Ryu, Ofer Moldavski, Tal Frolinger, Se Min Kim, Daria Lizneva, Tony Yuen, Mone Zaidi. Journal of Controlled Release

From discovery to therapeutic development of monoclonal antibodies. Satish Rojekar, Amol D. Gholap, Anusha R. Pallapati, Rauf Latif, Pavimol Angsantikul, Nagavendra Kommineni, Farhath Sultana, Anne Macdonald, Darya Vasilyeva, Steven Sims, Surabhi Parte, Clement Haeck, Rukmani Pandey, Judit Gimenez-Roig, Anisa Gumerova, Uliana Cheliadinova, Georgii Pevnev, Guzel Burganova, Zehra Tumoglu, Maryam Mansoori, Wei Yi, Orly Barak, Susan Hutchison, Francisco Fueyo González, Ki A.Goosens, Weibin Zhou, Vitaly Ryu, Ofer Moldavski, Tal Frolinger, Se Min Kim, Daria Lizneva, Tony Yuen, Mone Zaidi. Journal of Controlled Release

Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview. Mukta Lele, Ajit Manchare, Swapnali Parit, Amol D. Gholap, Krishna Jadhav, Navnath Hatvate, Keshav Raj Paudel, Satish Rojekar. MedComm

View All Publications

Atran Berg Laboratory Building Floor 4th Room AB 4-02

1428 Madison Ave

New York, NY 10029

646-256-9065

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Rojekar has not yet completed reporting of industry relationships or has no industry relationships to report.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.